Nanopass Technologies Ltd. Revenue and Competitors

Ness Ziona,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Nanopass Technologies Ltd.'s estimated annual revenue is currently $1.5M per year.(i)
  • Nanopass Technologies Ltd.'s estimated revenue per employee is $84,000

Employee Data

  • Nanopass Technologies Ltd. has 18 Employees.(i)
  • Nanopass Technologies Ltd. grew their employee count by 6% last year.

Nanopass Technologies Ltd.'s People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$14.1M1015%N/AN/A
#2
$1.6M19-71%N/AN/A
#3
$212.8M10635%$65MN/A
#4
$6.8M548%N/AN/A
#5
$12.9M922%$23.1MN/A
#6
$1M12N/AN/AN/A
#7
$106.5M599-17%$2.3MN/A
#8
$35.6M2316%N/AN/A
#9
$38.3M2495%N/AN/A
#10
$45M299-4%$102.6MN/A
Add Company

What Is Nanopass Technologies Ltd.?

NanoPass Technologies is a pioneer in the development and commercialization of painless intradermal (skin) delivery solutions and is currently sold throughout the world, from vaccines to aesthetics. NanoPass's IP-backed product, the MicronJet (registered with the US FDA, the EU, Brazil, China, Australia and other countries), is the most advanced hollow microneedles device available today. Its excellent performance is backed by more than 50 clinical studies. The Company has concluded the world's first intradermal pandemic flu vaccine study and additional seasonal flu studies, demonstrating equivalent or superior immunogenicity to standard delivery using only 20% of the dose. The company is backed by prominent Israeli and US investors ýand medical device companies, including IHCV, Ofer Hi-Tech, D-Partners, WFD Ventures and Elcam Medical. NanoPass recently closed a new round of financing, led by Israel Health Care Ventures (IHCV) NanoPass is continuously engaged in joint clinical development with top pharmaceutical companies, to demonstrate the benefits of its technology for various indications.

keywords:N/A

N/A

Total Funding

18

Number of Employees

$1.5M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Nanopass Technologies Ltd. News

2022-04-17 - Microneedle Drug Delivery Systems Market Size, Scope And ...

... LLC, NanoPass, Microdermics, Zosano Pharma Corp, Micropoint Technologies, MyLife Technologies, Innoture Medical Technology Limited,...

2022-04-17 - Advanced Drug Delivery Systems Market to record USD 91.79 ...

Ltd.: The company offers drug development efforts that are focused on two ... Exhibit 80: NanoPass Technologies Ltd. - Product and service.

2022-03-22 - Global Advanced Drug Delivery Market to Generate a Revenue

Opportunities: Persistent technological advancements and R&D activities ... Technologies., Takeda Pharmaceutical Company Limited., NanoPass,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.6M2310%N/A
#2
$8M3210%N/A
#3
N/A38-30%N/A
#4
$7.1M465%N/A
#5
$12.7M63-2%N/A